MY158522A - Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory diseases or condition - Google Patents
Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory diseases or conditionInfo
- Publication number
- MY158522A MY158522A MYPI2013000232A MYPI2013000232A MY158522A MY 158522 A MY158522 A MY 158522A MY PI2013000232 A MYPI2013000232 A MY PI2013000232A MY PI2013000232 A MYPI2013000232 A MY PI2013000232A MY 158522 A MY158522 A MY 158522A
- Authority
- MY
- Malaysia
- Prior art keywords
- pharmaceutical composition
- diseases
- condition
- methods
- conditions associated
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000023504 respiratory system disease Diseases 0.000 title 1
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 2
- 101800004538 Bradykinin Proteins 0.000 abstract 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 abstract 1
- 102100035792 Kininogen-1 Human genes 0.000 abstract 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 abstract 1
- 229960001340 histamine Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960005181 morphine Drugs 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Alternative & Traditional Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Otolaryngology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010130352/15A RU2528093C2 (ru) | 2010-07-21 | 2010-07-21 | Фармацевтическая композиция и способ лечения острых и хронических заболевания дыхательной системы и синдрома кашля |
| RU2011125992/15A RU2529783C2 (ru) | 2011-06-24 | 2011-06-24 | Лекарственное средство для лечения патологического синдрома и способ лечения острых и хронических заболеваний дыхательноый системы и синдрома кашля |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY158522A true MY158522A (en) | 2016-10-14 |
Family
ID=44899162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2013000232A MY158522A (en) | 2010-07-21 | 2011-07-15 | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory diseases or condition |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US8795657B2 (OSRAM) |
| EP (1) | EP2595655A2 (OSRAM) |
| JP (2) | JP2013533269A (OSRAM) |
| CN (1) | CN103200964A (OSRAM) |
| AR (1) | AR082313A1 (OSRAM) |
| AU (1) | AU2011281247B2 (OSRAM) |
| BR (1) | BR112013001297A2 (OSRAM) |
| CA (1) | CA2805978C (OSRAM) |
| CL (1) | CL2013000202A1 (OSRAM) |
| DE (1) | DE112011102412T5 (OSRAM) |
| EA (1) | EA029228B1 (OSRAM) |
| ES (1) | ES2425315R1 (OSRAM) |
| FR (1) | FR2962909A1 (OSRAM) |
| GB (1) | GB2496800B (OSRAM) |
| IT (1) | ITTO20110638A1 (OSRAM) |
| MX (1) | MX356678B (OSRAM) |
| MY (1) | MY158522A (OSRAM) |
| NZ (1) | NZ606977A (OSRAM) |
| PE (1) | PE20130387A1 (OSRAM) |
| PH (1) | PH12013500142A1 (OSRAM) |
| SG (1) | SG187579A1 (OSRAM) |
| WO (1) | WO2012010973A2 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| EP2593474A2 (en) | 2010-07-15 | 2013-05-22 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
| CZ2013105A3 (cs) | 2010-07-15 | 2013-05-22 | Iliich Epshtein@Oleg | Zpusob zvýsení úcinku aktivované potencované formy protilátky |
| WO2012010970A2 (en) | 2010-07-21 | 2012-01-26 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| BR112013001299A2 (pt) * | 2010-07-21 | 2017-11-21 | Lliich Epshtein Oleg | composições farmacêuticas e respectivo uso e métodos de tratamento de diabetes e doenças correlatas em paciente humano |
| AU2011281247B2 (en) * | 2010-07-21 | 2015-07-30 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition |
| BR112013001296A2 (pt) * | 2010-07-21 | 2017-12-19 | Lliich Epshtein Oleg | composições farmacêuticas e respectivo uso e métodos de tratamento de vertigem de diferentes origens, cinetose e distonia vascular vegetativa |
| CN103154030A (zh) * | 2010-08-06 | 2013-06-12 | 奥列格·伊里奇·爱泼斯坦 | 复合药物组合物以及对传染性疾病进行治疗和预防的方法 |
| RU2013111961A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| RU2013111962A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| DE102020007979A1 (de) | 2020-12-29 | 2022-06-30 | Charité Universitätsmedizin Institut für Mikrobiologie und Infektionsimmunologie | Zusammensetzung zur Behandlung von lnfektionen mit Coronaviren |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
| ATE155043T1 (de) | 1992-10-08 | 1997-07-15 | Kennedy Inst Of Rheumatology | Behandlung von autoimmun- und entzundungskrankheiten |
| IT1261849B (it) | 1993-09-02 | 1996-06-03 | Avantgarde Spa | Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici. |
| US5629286A (en) | 1994-03-31 | 1997-05-13 | Brewitt; Barbara | Homeopathic dilutions of growth factors |
| IL110035A0 (en) | 1994-06-16 | 1994-10-07 | Tapuach Natural Technologies 1 | Homeopathic formulations |
| JPH11509452A (ja) | 1996-02-12 | 1999-08-24 | イリイッチ エプシュテイン，アリグ | 薬物及び薬物によって生体を処置する方法 |
| US5834443A (en) * | 1996-05-21 | 1998-11-10 | Masiello; Domenick J. | Composition and method for treating herpes simplex |
| RU2114646C1 (ru) | 1996-09-30 | 1998-07-10 | Олег Ильич Эпштейн | Способ повышения защитных свойств организма при воздействии внешних физических факторов |
| RU2103999C1 (ru) | 1997-01-31 | 1998-02-10 | Олег Ильич Эпштейн | Способ лечения алкоголизма |
| RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2199244C2 (ru) * | 2000-10-05 | 2003-02-27 | Самофалова Лариса Александровна | Способ получения пищевой муки масличных семян |
| RU2197266C1 (ru) | 2001-06-01 | 2003-01-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения эрозивных и воспалительных заболеваний желудочно-кишечного тракта |
| RU2191602C1 (ru) | 2001-06-01 | 2002-10-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения аллергических и псевдоаллергических реакций |
| RU2206338C1 (ru) | 2001-12-07 | 2003-06-20 | Эпштейн Олег Ильич | Способ лечения синдрома кашля |
| RU2199344C1 (ru) | 2001-12-07 | 2003-02-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения синдрома кашля |
| RU2201255C1 (ru) | 2001-12-26 | 2003-03-27 | Эпштейн Олег Ильич | Лекарственное средство и способ регуляции сосудистого тонуса |
| RU2199345C1 (ru) | 2001-12-26 | 2003-02-27 | Эпштейн Олег Ильич | Лекарственное средство и способ регуляции углеводного и жирового обмена |
| RU2209083C1 (ru) | 2001-12-26 | 2003-07-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения кашля |
| UA76639C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| UA76641C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози |
| TWI345470B (en) | 2003-03-14 | 2011-07-21 | Nutrition Res Inc | Homeopathic formulations useful for treating pain and/or inflammation |
| RU2253478C1 (ru) | 2003-10-01 | 2005-06-10 | Эпштейн Олег Ильич | Средство для потенцирования лечебных эффектов - усиления действия лекарственного вещества |
| CA2654408C (en) * | 2006-06-06 | 2018-05-08 | Oleg Iliich Epshtein | Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance |
| CN102014939A (zh) * | 2008-04-29 | 2011-04-13 | 贡万特·德维昌德·奥斯瓦尔 | 顺势疗法配方产品 |
| DE112011102349T5 (de) * | 2010-07-15 | 2013-04-18 | Oleg Iliich Epshtein | Pharmazeutische Zusammensetzung und Behandlungsverfahren |
| EP2593474A2 (en) | 2010-07-15 | 2013-05-22 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
| JP2013532181A (ja) | 2010-07-15 | 2013-08-15 | イリイチ・エプシテイン オレグ | 組み合わせ医薬組成物及び胃腸管の機能的な疾患又は状態を治療する方法 |
| ES2425314R1 (es) | 2010-07-15 | 2014-07-09 | Oleg Iliich Epshtein | Composición farmacéutica combinada y uso para preparar medicamentos destinados al tratamiento de trastornos del sistema genitourinario |
| BR112013001296A2 (pt) | 2010-07-21 | 2017-12-19 | Lliich Epshtein Oleg | composições farmacêuticas e respectivo uso e métodos de tratamento de vertigem de diferentes origens, cinetose e distonia vascular vegetativa |
| AU2011281247B2 (en) * | 2010-07-21 | 2015-07-30 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition |
| BR112013001299A2 (pt) * | 2010-07-21 | 2017-11-21 | Lliich Epshtein Oleg | composições farmacêuticas e respectivo uso e métodos de tratamento de diabetes e doenças correlatas em paciente humano |
| CN103154030A (zh) | 2010-08-06 | 2013-06-12 | 奥列格·伊里奇·爱泼斯坦 | 复合药物组合物以及对传染性疾病进行治疗和预防的方法 |
-
2011
- 2011-07-15 AU AU2011281247A patent/AU2011281247B2/en not_active Ceased
- 2011-07-15 WO PCT/IB2011/002346 patent/WO2012010973A2/en not_active Ceased
- 2011-07-15 PE PE2013000107A patent/PE20130387A1/es not_active Application Discontinuation
- 2011-07-15 GB GB1302926.9A patent/GB2496800B/en not_active Expired - Fee Related
- 2011-07-15 PH PH1/2013/500142A patent/PH12013500142A1/en unknown
- 2011-07-15 SG SG2013004825A patent/SG187579A1/en unknown
- 2011-07-15 IT IT000638A patent/ITTO20110638A1/it unknown
- 2011-07-15 BR BR112013001297A patent/BR112013001297A2/pt not_active Application Discontinuation
- 2011-07-15 MY MYPI2013000232A patent/MY158522A/en unknown
- 2011-07-15 FR FR1156475A patent/FR2962909A1/fr not_active Withdrawn
- 2011-07-15 ES ES201390008A patent/ES2425315R1/es active Pending
- 2011-07-15 JP JP2013520239A patent/JP2013533269A/ja active Pending
- 2011-07-15 EP EP11778681.4A patent/EP2595655A2/en not_active Ceased
- 2011-07-15 NZ NZ606977A patent/NZ606977A/en not_active IP Right Cessation
- 2011-07-15 MX MX2013000806A patent/MX356678B/es active IP Right Grant
- 2011-07-15 CA CA2805978A patent/CA2805978C/en not_active Expired - Fee Related
- 2011-07-15 US US13/135,884 patent/US8795657B2/en active Active
- 2011-07-15 DE DE112011102412T patent/DE112011102412T5/de not_active Withdrawn
- 2011-07-15 CN CN2011800455711A patent/CN103200964A/zh active Pending
- 2011-07-15 EA EA201300131A patent/EA029228B1/ru not_active IP Right Cessation
- 2011-07-21 AR ARP110102643A patent/AR082313A1/es unknown
-
2013
- 2013-01-21 CL CL2013000202A patent/CL2013000202A1/es unknown
-
2014
- 2014-07-11 US US14/328,792 patent/US20150023985A1/en not_active Abandoned
-
2016
- 2016-07-01 JP JP2016131753A patent/JP2016216479A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PH12013500142A1 (en) | 2013-03-11 |
| MX356678B (es) | 2018-06-08 |
| CN103200964A (zh) | 2013-07-10 |
| GB2496800A (en) | 2013-05-22 |
| EP2595655A2 (en) | 2013-05-29 |
| MX2013000806A (es) | 2013-10-28 |
| WO2012010973A3 (en) | 2012-04-26 |
| CL2013000202A1 (es) | 2015-01-16 |
| SG187579A1 (en) | 2013-03-28 |
| GB201302926D0 (en) | 2013-04-03 |
| EA029228B1 (ru) | 2018-02-28 |
| ES2425315R1 (es) | 2014-09-08 |
| WO2012010973A2 (en) | 2012-01-26 |
| DE112011102412T5 (de) | 2013-07-04 |
| AR082313A1 (es) | 2012-11-28 |
| BR112013001297A2 (pt) | 2017-11-21 |
| GB2496800B (en) | 2018-05-23 |
| JP2013533269A (ja) | 2013-08-22 |
| ITTO20110638A1 (it) | 2012-01-22 |
| FR2962909A1 (fr) | 2012-01-27 |
| PE20130387A1 (es) | 2013-03-30 |
| CA2805978C (en) | 2016-06-28 |
| AU2011281247A1 (en) | 2013-03-14 |
| ES2425315A2 (es) | 2013-10-14 |
| US8795657B2 (en) | 2014-08-05 |
| CA2805978A1 (en) | 2012-01-26 |
| US20150023985A1 (en) | 2015-01-22 |
| EA201300131A1 (ru) | 2013-11-29 |
| NZ606977A (en) | 2015-08-28 |
| US20120225074A1 (en) | 2012-09-06 |
| AU2011281247B2 (en) | 2015-07-30 |
| JP2016216479A (ja) | 2016-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY158522A (en) | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory diseases or condition | |
| AU2018253544A1 (en) | Methods for treating or preventing asthma by administering an IL-4R antagonist | |
| CA2897464C (en) | Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide | |
| BR112012001297A2 (pt) | conector. | |
| NZ750754A (en) | Methods of treating eosinophilic esophagitis | |
| WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
| PH12014500468A1 (en) | Heterocyclic compounds and uses thereof | |
| MY157564A (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
| MX2015010829A (es) | Compuestos terapeuticos y sus usos. | |
| SG10201803778PA (en) | Treatment for rheumatoid arthritis | |
| HK1217092A1 (zh) | 治疗性化合物及其用途 | |
| EA201290603A1 (ru) | Способ лечения | |
| GB2496795A (en) | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system | |
| MX356317B (es) | Tratamiento de síntomas asociados a gastroparesia femenina. | |
| WO2011060253A3 (en) | Methods of treating diseases, pharmaceutical compositions, and pharmaceutical dosage forms | |
| WO2013153349A3 (en) | Pharmaceutical composition comprising arformoterol and fluticasone furoate | |
| MX368641B (es) | Compuestos para el tratamiento de inflamación y dolor. | |
| PH12014500684A1 (en) | Treatment of rhinitis | |
| MX368640B (es) | Composición farmacéutica para tratar inflamación y dolor. | |
| WO2012149295A3 (en) | Methods of administering anatabine to treat autism spectrum disorders and seizure disorders | |
| MY169877A (en) | Treatment of malphigia coccigera on liver cirrhosis | |
| MX2012014799A (es) | Composición medicinal, método de preparación y uso de la misma. | |
| UA59177U (ru) | Способ лечения больных с синдромом повышенной усталости, соединенным с хронической патологией гепатобилиарной системы | |
| UA55818U (ru) | Способ лечения хронических заболеваний роговицы | |
| UA89921C2 (ru) | Способ лечения хронического обструктивного заболевания лёгких при помощи месалазина |